Biochemical markers of bone metabolism in relation to adrenocortical and growth suppression during the initiation phase of inhaled steroid therapy

Pediatric Research

Volumn 52, Issue 2, 2002, Pages 258-262

  Kannisto, Senja ^a   Korppi, Matti ^a   Arikoski, Pekka ^a   Remes, Kyllikki ^a   Voutilainen, Raimo ^a  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; BUDESONIDE; CHROMONE DERIVATIVE; CORTICOTROPIN; CROMOGLYCATE DISODIUM; FLUTICASONE PROPIONATE; NEDOCROMIL SODIUM; OSTEOCALCIN; PROCOLLAGEN C PROTEINASE; STEROID; TYPE 1 COLLAGEN CARBOXYTERMINAL TELOPEPTIDE; UNCLASSIFIED DRUG; ANDROSTANE DERIVATIVE; ANTIINFLAMMATORY AGENT; BIOLOGICAL MARKER; FLUTICASONE;

ADRENAL SUPPRESSION; ARTICLE; ASTHMA; BLOOD LEVEL; BONE METABOLISM; CONTROLLED STUDY; CORTICOTROPIN TEST; DOSE RESPONSE; EVALUATION; FEMALE; GROWTH INHIBITION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; PRIORITY JOURNAL; SCHOOL CHILD; SCORING SYSTEM; STEROID THERAPY; ADRENAL CORTEX; BONE; BONE DEVELOPMENT; CHILD; DRUG EFFECT; GROWTH, DEVELOPMENT AND AGING; INHALATIONAL DRUG ADMINISTRATION; METABOLISM; PHYSIOLOGY; PRESCHOOL CHILD;

ADMINISTRATION, INHALATION; ADRENAL CORTEX; ANDROSTADIENES; ANTI-INFLAMMATORY AGENTS; ASTHMA; BIOLOGICAL MARKERS; BONE AND BONES; BONE DEVELOPMENT; BUDESONIDE; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE;

EID: 85047681423     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/00006450-200208000-00019     Document Type: Article

References (39)

1. Effect of long-term treatment with inhaled budesonide on adult height in children with asthma
2. Endocrine and lung function in asthmatic children on inhaled corticosteroids
3. Adrenal suppression, evaluated by a low-dose ACTH-test, and growth in asthmatic children treated with inhaled steroids
4. Growth of asthmatic children during treatment with budesonide: A double blind trial
5. Growth of prepubertal children with mild asthma treated with inhaled beclomethasone dipropionate
6. Effect of inhaled budesonide on serum markers of bone metabolism in children with asthma
7. Collagen metabolism and growth in prepubertal children with asthma treated with inhaled steroids
8. Effects of short term glucocorticoid administration on intestinal calcium absorption and circulating vitamin D metabolite concentrations in man
9. Importance of increased urinary calcium excretion in the development of secondary hyperparathyroidism of patients under glucocorticoid therapy
10. Dose-related decrease in bone density among asthmatic patients treated with inhaled corticosteroids
11. Bone mineral density in perimenopausal women with asthma
12. Inhaled corticosteroid use and bonemineral density in patients with asthma
13. Dose-response relation of inhaled fluticasone propionate in adolescents and adults with asthma: Meta-analysis
14. Systemic adverse effects of inhaled corticosteroid therapy: A systematic review and meta-analysis
15. Serum bone GLA-protein: A specific marker for bone formation in postmenopausal osteoporosis
16. Biochemical markers of bone turnover for the clinical assessment of metabolic bone disease
17. Procollagen type I carboxyterminal extension peptide in serum as a marker of collagen biosynthesis in bone: Correlation with iliac bone formation rates and comparison with total alkaline phosphatase
18. Biochemical markers of bone metabolism
19. Changes in bone markers in children with asthma during inhaled budesonide and nedocromil treatments
20. Radioimmunoassay for the pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen: A new serum marker of bone collagen degradation
21. Glucocorticoid receptors and fluticasone propionate
22. Efficacy and safety of high-dose inhaled steroids in children with asthma: A comparison of fluticasone propionate with budesonide
23. A novel format for a growth chart
24. Serum concentrations of carboxyl-terminal propeptide of type I procollagen, amino-terminal propeptide of type III procollagen, cross-linked carboxyl-terminal telopeptide of type collagen, and their interrelationships in schoolchildren
25. New markers of bone metabolism: Clinical use in metabolic bone disease
26. Bone and collagen turnover during treatment with inhaled dry powder budesonide and beclomethasone dipropionate
27. Systemic effects of a short course of betamethasone compared with high-dose inhaled budesonide in early childhood asthma
28. Bone density in asthmatic children treated with inhaled steroids
29. Serum bone Gla-protein as a marker of bone growth in children and adolescents: Correlation with age, height, serum insulin-like growth factor I, and serum testosterone
30. Serum concentration of the type I and III procollagen propeptides as biochemical markers of growth velocity in healthy infants and children and in children with growth disorders
31. Molecular basis and clinical application of biological markers of bone turnover
32. Fluticasone propionate compared with budesonide: A double-blind trial in asthmatic children using powder devices at a dosage of 400 μg/day
33. Bone metabolism in children with asthma treated with inhaled beclomethasone dipropionate
34. Effect on cortical and trabecular bone mass of different anti-inflammatory treatments in preadolescent children with chronic asthma
35. Longitudinal evaluation of bone mass in asthmatic children treated with inhaled beclomethasone dipropionate or cromolyn sodium
36. Systemic effects of inhaled corticosteroids on growth and bone turnover in childhood asthma: Comparison of fluticasone with beclomethasone
37. Effects of high-dose inhaled corticosteroids on bone metabolism in prepubertal children with asthma
38. Effects of long-term treatment with growth hormone on bone and mineral metabolism in children with growth hormone deficiency
39. Growth of asthmatic children is slower during than before treatment with inhaled glucocorticoids